Ibogaine as a lifeline for addiction and PTSD: Colorado decriminalization and clinic use in Mexico

Ibogaine is presented as a potential lifeline for people dealing with opioid addiction and severe trauma symptoms, with Colorado decriminalization in 2022 framed as a key step toward wider access. The article centers on two parallel first-person pathways: AnneClaire Stapleton, who sought ibogaine for PTSD and grief after years of professional compartmentalizing, and Kevin Franciotti, who used ibogaine as a “compassionate detox” to interrupt opioid withdrawal after multiple failed attempts at recovery. It also connects personal accounts to policy momentum, noting Colorado’s Natural Medicine Advisory Board recommendation for introducing ibogaine into natural medicine healing centers and describing broader national interest in funding clinical trials while implementation and sourcing challenges remain unresolved.